ReviewPharmaceuticals (Basel, Switzerland)2026

Drug-Induced Amyloid-Related Imaging Abnormalities: A Neurovascular Perspective on Risk Assessment.

Marialuisa Zedde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.